GAM Holding’s Neurocrine Biosciences NBIX Stock Holding History

GAM Holding’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,568	Closed	-$1.23M	–	253
2022 Q2	$1.23M	Hold	12,568	–	–	0.08%	175
2022 Q1	$1.18M	Hold	12,568	–	–	0.06%	190
2021 Q4	$1.07M	Hold	12,568	–	–	0.05%	195
2021 Q3	$1.21M	Sell	12,568 -3,013	-19%	-$289K	0.06%	196
2021 Q2	$1.52M	Sell	15,581 -4,123	-21%	-$401K	0.07%	200
2021 Q1	$1.92M	Buy	+19,704	New	+$1.92M	0.09%	203
2020 Q4	–	Sell	-84,618	Closed	-$8.14M	–	308
2020 Q3	$8.14M	Buy	84,618 +11	+0%	+$1.06K	0.49%	55
2020 Q2	$10.3M	Sell	84,607 -7	-0%	-$854	0.64%	36
2020 Q1	$7.32M	Sell	84,614 -3,896	-4%	-$337K	0.5%	53
2019 Q4	$9.51M	Buy	88,510 +3	+0%	+$322	0.45%	57
2019 Q3	$7.98M	Hold	88,507	–	–	0.35%	75
2019 Q2	$7.47M	Buy	88,507 +8,100	+10%	+$684K	0.29%	88
2019 Q1	$7.08M	Buy	80,407 +28,007	+53%	+$2.47M	0.3%	86
2018 Q4	$3.74M	Sell	52,400 -6,300	-11%	-$450K	0.19%	132
2018 Q3	$7.22M	Sell	58,700 -51,600	-47%	-$6.34M	0.26%	105
2018 Q2	$10.8M	Hold	110,300	–	–	0.38%	71
2018 Q1	$9.15M	Sell	110,300 -8,900	-7%	-$738K	0.32%	79
2017 Q4	$9.25M	Hold	119,200	–	–	0.28%	88
2017 Q3	$7.31M	Hold	119,200	–	–	0.31%	93
2017 Q2	$5.48M	Buy	119,200 +4,300	+4%	+$198K	0.08%	298
2017 Q1	$4.98M	Buy	114,900 +8,400	+8%	+$364K	0.08%	307
2016 Q4	$4.12M	Buy	+106,500	New	+$4.12M	0.07%	310
2016 Q3	–	Sell	-44,000	Closed	-$2M	–	958
2016 Q2	$2M	Sell	44,000 -15,300	-26%	-$695K	0.03%	521
2016 Q1	$2.35M	Buy	59,300 +9,600	+19%	+$380K	0.04%	441
2015 Q4	$2.81M	Buy	+49,700	New	+$2.81M	0.04%	410
2015 Q1	–	Sell	-100,000	Closed	-$2.23M	–	1110
2014 Q4	$2.23M	Buy	100,000 +63,000	+170%	+$1.41M	0.03%	478
2014 Q3	$580K	Hold	37,000	–	–	0.01%	815
2014 Q2	$549K	Hold	37,000	–	–	0.01%	815
2014 Q1	$596K	Hold	37,000	–	–	0.01%	791
2013 Q4	$346K	Buy	37,000 +10,000	+37%	+$93.5K	0.01%	731
2013 Q3	$306K	Buy	27,000 +19,000	+238%	+$215K	0.01%	882
2013 Q2	$107K	Buy	+8,000	New	+$107K	﹤0.01%	822